<code id='30EAD7A3DD'></code><style id='30EAD7A3DD'></style>
    • <acronym id='30EAD7A3DD'></acronym>
      <center id='30EAD7A3DD'><center id='30EAD7A3DD'><tfoot id='30EAD7A3DD'></tfoot></center><abbr id='30EAD7A3DD'><dir id='30EAD7A3DD'><tfoot id='30EAD7A3DD'></tfoot><noframes id='30EAD7A3DD'>

    • <optgroup id='30EAD7A3DD'><strike id='30EAD7A3DD'><sup id='30EAD7A3DD'></sup></strike><code id='30EAD7A3DD'></code></optgroup>
        1. <b id='30EAD7A3DD'><label id='30EAD7A3DD'><select id='30EAD7A3DD'><dt id='30EAD7A3DD'><span id='30EAD7A3DD'></span></dt></select></label></b><u id='30EAD7A3DD'></u>
          <i id='30EAD7A3DD'><strike id='30EAD7A3DD'><tt id='30EAD7A3DD'><pre id='30EAD7A3DD'></pre></tt></strike></i>

          entertainment

          entertainment

          author:entertainment    Page View:192
          Bruce Broussard. -- health business coverage from STAT
          Humana CEO Bruce Broussard Jason DeCrow/AP

          Bruce Broussard, CEO of health insurance giant Humana, will step down next year after leading the company for more than a decade.

          Humana named Jim Rechtin — who is the CEO of Envision Healthcare, the controversial physician staffing firm that is working its way through bankruptcy — as Broussard’s replacement. Rechtin will serve as president and chief operating officer starting Jan. 8 and then take over as CEO in the “latter half of 2024,” the company said in a news release.

          advertisement

          Humana’s stock fell by more than 2% on the news Wednesday morning.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          knowledge

          Wildfire smoke exposes gaps in outdoor worker protections
          Wildfire smoke exposes gaps in outdoor worker protections

          ApersonwaitingforthesubwaywearsafilteredmaskassmokyhazefromwildfiresinCanadablanketsaneighborhoodinN

          read more
          ASCO: AstraZeneca's hat trick, and palliative care's spotlight
          ASCO: AstraZeneca's hat trick, and palliative care's spotlight

          "Arrestingcancer."ADAMFEUERSTEIN/STATYou’rereadingthewebeditionofASCOin30Seconds,STAT’sguidetotheAme

          read more
          Medicare proposal to cover medical devices draws a mixed reaction
          Medicare proposal to cover medical devices draws a mixed reaction

          AdobeThemedicaldeviceindustryissplitonwhetheraproposednewMedicarereimbursementpathwaywilldoanythingt

          read more

          ASCO24: AstraZeneca won cancer’s big meeting. Can it fulfill its $80B ambition?

          SusanGalbraith,AstraZeneca’sheadofcancerresearchanddevelopment,speaksataSTATeventin2023.MarieMillerf